Along with other organizations, SHM signed onto a letter urging CMS to reduce the reporting period for MIPS reporting.

SHM submitted comments to the Ways and Means Committee and subcommittee on health regarding the opioid epidemic.

Along with other organizations, SHM signs onto a letter requesting incentives for new antimicrobial research within the Pandemic and All-Hazards Preparedness Act (PAHPA).

SHM provides feedback to CMS on new hospital harm measures under development, including acute kidney injury, pressure ulcers, and opioid adverse events.

SHM responds to the Senate Finance Committee request for feedback on policies to address the opioid epidemic.

SHM sends letters supporting the Medicare Choices and Empowerment Act, which gives patients access to end of life care.

SHM submitted comments to Medicare via the development of episode-based cost measures in MIPS.

SHM submitted comments on aspects of the Inpatient Prospective Payment System (IPPS), including updated measure sets and the NOTICE Act requirements surrounding observation status.

SHM sends letter to CMS Administrator Verma and HHS Secretary Price on reducing the regulatory burden in PQRS, VM, and MU programs.

SHM supports Representative Price’s bill, which would delay the mandatory CJR payment model.